Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1951 1
1957 3
1958 1
1963 1
1964 1
1965 1
1966 1
1971 3
1972 1
1973 3
1975 1
1977 1
1978 1
1979 1
1980 1
1982 2
1983 1
1985 5
1986 1
1988 2
1989 1
1990 8
1991 2
1992 1
1993 3
1994 2
1995 4
1996 2
1997 5
1998 5
1999 4
2000 5
2001 8
2002 4
2003 3
2004 6
2005 12
2006 8
2007 7
2008 12
2009 3
2010 14
2011 18
2012 28
2013 31
2014 34
2015 19
2016 18
2017 24
2018 14
2019 20
2020 16
2021 9
2022 15
2023 16
2024 15
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

368 results

Results by year

Filters applied: . Clear all
Page 1
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12. J Clin Oncol. 2024. PMID: 38471061 Free PMC article. Clinical Trial.
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies.
Kongtim P, Vittayawacharin P, Zou J, Srour S, Shaffer B, Shapiro RM, Varma A, McGuirk J, Dholaria BR, McCurdy SR, DeZern AE, Bejanyan N, Bashey A, Furst S, Castagna L, Mariotti J, Ruggeri A, Bailen R, Teshima T, Xiao-Jun H, Bonfim C, Aung F, Cao K, Carpenter PA, Hamadani M, Askar M, Fernandez-Vina M, Girnita A, Ciurea SO. Kongtim P, et al. Among authors: furst s. Transplant Cell Ther. 2024 Dec;30(12):1139-1154. doi: 10.1016/j.jtct.2024.09.005. Epub 2024 Sep 10. Transplant Cell Ther. 2024. PMID: 39260570 Review.
Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans.
Smith SH, Jayawickreme C, Rickard DJ, Nicodeme E, Bui T, Simmons C, Coquery CM, Neil J, Pryor WM, Mayhew D, Rajpal DK, Creech K, Furst S, Lee J, Wu D, Rastinejad F, Willson TM, Viviani F, Morris DC, Moore JT, Cote-Sierra J. Smith SH, et al. Among authors: furst s. J Invest Dermatol. 2017 Oct;137(10):2110-2119. doi: 10.1016/j.jid.2017.05.004. Epub 2017 Jun 6. J Invest Dermatol. 2017. PMID: 28595996 Free article.
TURBOMOLE: Today and Tomorrow.
Franzke YJ, Holzer C, Andersen JH, Begušić T, Bruder F, Coriani S, Della Sala F, Fabiano E, Fedotov DA, Fürst S, Gillhuber S, Grotjahn R, Kaupp M, Kehry M, Krstić M, Mack F, Majumdar S, Nguyen BD, Parker SM, Pauly F, Pausch A, Perlt E, Phun GS, Rajabi A, Rappoport D, Samal B, Schrader T, Sharma M, Tapavicza E, Treß RS, Voora V, Wodyński A, Yu JM, Zerulla B, Furche F, Hättig C, Sierka M, Tew DP, Weigend F. Franzke YJ, et al. Among authors: furst s. J Chem Theory Comput. 2023 Oct 24;19(20):6859-6890. doi: 10.1021/acs.jctc.3c00347. Epub 2023 Jun 29. J Chem Theory Comput. 2023. PMID: 37382508 Free PMC article. Review.
Opioid-Based Haptens: Development of Immunotherapy.
Hosztafi S, Galambos AR, Köteles I, Karádi DÁ, Fürst S, Al-Khrasani M. Hosztafi S, et al. Among authors: furst s. Int J Mol Sci. 2024 Jul 16;25(14):7781. doi: 10.3390/ijms25147781. Int J Mol Sci. 2024. PMID: 39063024 Free PMC article. Review.
PET/MR: a paradigm shift.
Gaertner FC, Fürst S, Schwaiger M. Gaertner FC, et al. Among authors: furst s. Cancer Imaging. 2013 Feb 27;13(1):36-52. doi: 10.1102/1470-7330.2013.0005. Cancer Imaging. 2013. PMID: 23446110 Free PMC article. Review.
Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry.
Rabian F, Beauvais D, Marchand T, Fürst S, Huynh A, Brissot E, Maury S, Gabellier L, Chevallier P, Loschi M, Nguyen S, Balsat M, Lafon I, Fayard A, Camus V, Simand C, Moya N, Castilla-Llorente C, Joris M, Berceanu A, Thiebaut-Bertrand A, Lhéritier V, Gehlkopf E, Roth-Guépin G, Leguay T, Boissel N. Rabian F, et al. Among authors: furst s. Blood Adv. 2024 Nov 12;8(21):5493-5496. doi: 10.1182/bloodadvances.2024013962. Blood Adv. 2024. PMID: 39207868 Free PMC article. No abstract available.
[Cancer care for women in Germany - what is new since 2020?].
Kunstein A, Fürst S, Röbl-Mathieu M, Mahner S. Kunstein A, et al. Among authors: furst s. MMW Fortschr Med. 2022 Sep;164(16):42-45. doi: 10.1007/s15006-022-1822-y. MMW Fortschr Med. 2022. PMID: 36123484 Review. German. No abstract available.
368 results